Loading…

The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation

A high concentration of low-density lipoproteins (LDLs) in circulation has been well-known as a major risk factor for cardiovascular diseases. The presence of oxidized LDLs (oxLDLs) in atherosclerotic lesions and circulation was demonstrated using anti-oxLDL monoclonal antibodies. The so-called &quo...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2023-03, Vol.24 (6), p.5747
Main Authors: Itabe, Hiroyuki, Obama, Takashi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c546t-434ab210582af0f7743e35b686b47b7909710d21347448aa2c29e326abc072e23
cites cdi_FETCH-LOGICAL-c546t-434ab210582af0f7743e35b686b47b7909710d21347448aa2c29e326abc072e23
container_end_page
container_issue 6
container_start_page 5747
container_title International journal of molecular sciences
container_volume 24
creator Itabe, Hiroyuki
Obama, Takashi
description A high concentration of low-density lipoproteins (LDLs) in circulation has been well-known as a major risk factor for cardiovascular diseases. The presence of oxidized LDLs (oxLDLs) in atherosclerotic lesions and circulation was demonstrated using anti-oxLDL monoclonal antibodies. The so-called "oxLDL hypothesis", as a mechanism for atherosclerosis development, has been attracting attention for decades. However, the oxLDL has been considered a hypothetical particle since the oxLDL present in vivo has not been fully characterized. Several chemically modified LDLs have been proposed to mimic oxLDLs. Some of the subfractions of LDL, especially Lp(a) and electronegative LDL, have been characterized as oxLDL candidates as oxidized phospholipids that stimulate vascular cells. Oxidized high-density lipoprotein (oxHDL) and oxLDL were discovered immunologically in vivo. Recently, an oxLDL-oxHDL complex was found in human plasma, suggesting the involvement of HDLs in the oxidative modification of lipoproteins in vivo. In this review, we summarize our understanding of oxidized lipoproteins and propose a novel standpoint to understand the oxidized lipoproteins present in vivo.
doi_str_mv 10.3390/ijms24065747
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10053446</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A751926824</galeid><sourcerecordid>A751926824</sourcerecordid><originalsourceid>FETCH-LOGICAL-c546t-434ab210582af0f7743e35b686b47b7909710d21347448aa2c29e326abc072e23</originalsourceid><addsrcrecordid>eNptkk1vEzEQQC1ERUvhxhlZ4sKBFH97zaUqAdpIkXopvVreXW8z0a4d7N2I8utx1NKmqPLBlufNs2Y8CL2j5IRzQz7DeshMECW10C_QERWMzQhR-uXe-RC9znlNCONMmlfokCtTsYrKI3R9tfL48je08Me3eAmbuElx9BAyXgR8Ddv4BS_GjL_B1qcM4y12ocVf_cptISYMAY9FcDENLuA5pGbq3QgxvEEHneuzf3u_H6OfP75fzS9my8vzxfxsOWukUONMcOFqRomsmOtIp7XgnstaVaoWutaGGE1JyygXWojKOdYw4zlTrm6IZp7xY3R6591M9eDbxocxud5uEgwu3drowD6NBFjZm7i1lBDJhVDF8PHekOKvyefRDpAb3_cu-Dhly7RhknCieUE__Ieu45RCqW9HUSVVRc0jdeN6byF0sTzc7KT2TEtqmKqYKNTJM1RZrR-gicF3UO6fJHy6S2hSzDn57qFISuxuEOz-IBT8_X5jHuB_P8__ApGVq9M</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2791656819</pqid></control><display><type>article</type><title>The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Itabe, Hiroyuki ; Obama, Takashi</creator><creatorcontrib>Itabe, Hiroyuki ; Obama, Takashi</creatorcontrib><description>A high concentration of low-density lipoproteins (LDLs) in circulation has been well-known as a major risk factor for cardiovascular diseases. The presence of oxidized LDLs (oxLDLs) in atherosclerotic lesions and circulation was demonstrated using anti-oxLDL monoclonal antibodies. The so-called "oxLDL hypothesis", as a mechanism for atherosclerosis development, has been attracting attention for decades. However, the oxLDL has been considered a hypothetical particle since the oxLDL present in vivo has not been fully characterized. Several chemically modified LDLs have been proposed to mimic oxLDLs. Some of the subfractions of LDL, especially Lp(a) and electronegative LDL, have been characterized as oxLDL candidates as oxidized phospholipids that stimulate vascular cells. Oxidized high-density lipoprotein (oxHDL) and oxLDL were discovered immunologically in vivo. Recently, an oxLDL-oxHDL complex was found in human plasma, suggesting the involvement of HDLs in the oxidative modification of lipoproteins in vivo. In this review, we summarize our understanding of oxidized lipoproteins and propose a novel standpoint to understand the oxidized lipoproteins present in vivo.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms24065747</identifier><identifier>PMID: 36982815</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Arteriosclerosis ; Atherosclerosis ; Atherosclerosis - etiology ; Blood lipids ; Blood plasma ; Cardiovascular diseases ; Cardiovascular Diseases - complications ; Cholesterol ; Development and progression ; Electronegativity ; Enzymes ; High density lipoprotein ; Human acts ; Human behavior ; Humans ; Hypothetical particles ; Ligands ; Lipids ; Lipoprotein A ; Lipoproteins ; Lipoproteins, HDL ; Lipoproteins, LDL ; Low density lipoprotein ; Low density lipoprotein receptors ; Low density lipoproteins ; Medical research ; Membrane lipids ; Monoclonal antibodies ; Oxidation ; Phospholipids ; Plasma ; Proteins ; Review ; Risk Factors</subject><ispartof>International journal of molecular sciences, 2023-03, Vol.24 (6), p.5747</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c546t-434ab210582af0f7743e35b686b47b7909710d21347448aa2c29e326abc072e23</citedby><cites>FETCH-LOGICAL-c546t-434ab210582af0f7743e35b686b47b7909710d21347448aa2c29e326abc072e23</cites><orcidid>0000-0002-8044-9494</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2791656819/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2791656819?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36982815$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Itabe, Hiroyuki</creatorcontrib><creatorcontrib>Obama, Takashi</creatorcontrib><title>The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>A high concentration of low-density lipoproteins (LDLs) in circulation has been well-known as a major risk factor for cardiovascular diseases. The presence of oxidized LDLs (oxLDLs) in atherosclerotic lesions and circulation was demonstrated using anti-oxLDL monoclonal antibodies. The so-called "oxLDL hypothesis", as a mechanism for atherosclerosis development, has been attracting attention for decades. However, the oxLDL has been considered a hypothetical particle since the oxLDL present in vivo has not been fully characterized. Several chemically modified LDLs have been proposed to mimic oxLDLs. Some of the subfractions of LDL, especially Lp(a) and electronegative LDL, have been characterized as oxLDL candidates as oxidized phospholipids that stimulate vascular cells. Oxidized high-density lipoprotein (oxHDL) and oxLDL were discovered immunologically in vivo. Recently, an oxLDL-oxHDL complex was found in human plasma, suggesting the involvement of HDLs in the oxidative modification of lipoproteins in vivo. In this review, we summarize our understanding of oxidized lipoproteins and propose a novel standpoint to understand the oxidized lipoproteins present in vivo.</description><subject>Arteriosclerosis</subject><subject>Atherosclerosis</subject><subject>Atherosclerosis - etiology</subject><subject>Blood lipids</subject><subject>Blood plasma</subject><subject>Cardiovascular diseases</subject><subject>Cardiovascular Diseases - complications</subject><subject>Cholesterol</subject><subject>Development and progression</subject><subject>Electronegativity</subject><subject>Enzymes</subject><subject>High density lipoprotein</subject><subject>Human acts</subject><subject>Human behavior</subject><subject>Humans</subject><subject>Hypothetical particles</subject><subject>Ligands</subject><subject>Lipids</subject><subject>Lipoprotein A</subject><subject>Lipoproteins</subject><subject>Lipoproteins, HDL</subject><subject>Lipoproteins, LDL</subject><subject>Low density lipoprotein</subject><subject>Low density lipoprotein receptors</subject><subject>Low density lipoproteins</subject><subject>Medical research</subject><subject>Membrane lipids</subject><subject>Monoclonal antibodies</subject><subject>Oxidation</subject><subject>Phospholipids</subject><subject>Plasma</subject><subject>Proteins</subject><subject>Review</subject><subject>Risk Factors</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkk1vEzEQQC1ERUvhxhlZ4sKBFH97zaUqAdpIkXopvVreXW8z0a4d7N2I8utx1NKmqPLBlufNs2Y8CL2j5IRzQz7DeshMECW10C_QERWMzQhR-uXe-RC9znlNCONMmlfokCtTsYrKI3R9tfL48je08Me3eAmbuElx9BAyXgR8Ddv4BS_GjL_B1qcM4y12ocVf_cptISYMAY9FcDENLuA5pGbq3QgxvEEHneuzf3u_H6OfP75fzS9my8vzxfxsOWukUONMcOFqRomsmOtIp7XgnstaVaoWutaGGE1JyygXWojKOdYw4zlTrm6IZp7xY3R6591M9eDbxocxud5uEgwu3drowD6NBFjZm7i1lBDJhVDF8PHekOKvyefRDpAb3_cu-Dhly7RhknCieUE__Ieu45RCqW9HUSVVRc0jdeN6byF0sTzc7KT2TEtqmKqYKNTJM1RZrR-gicF3UO6fJHy6S2hSzDn57qFISuxuEOz-IBT8_X5jHuB_P8__ApGVq9M</recordid><startdate>20230317</startdate><enddate>20230317</enddate><creator>Itabe, Hiroyuki</creator><creator>Obama, Takashi</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8044-9494</orcidid></search><sort><creationdate>20230317</creationdate><title>The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation</title><author>Itabe, Hiroyuki ; Obama, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c546t-434ab210582af0f7743e35b686b47b7909710d21347448aa2c29e326abc072e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Arteriosclerosis</topic><topic>Atherosclerosis</topic><topic>Atherosclerosis - etiology</topic><topic>Blood lipids</topic><topic>Blood plasma</topic><topic>Cardiovascular diseases</topic><topic>Cardiovascular Diseases - complications</topic><topic>Cholesterol</topic><topic>Development and progression</topic><topic>Electronegativity</topic><topic>Enzymes</topic><topic>High density lipoprotein</topic><topic>Human acts</topic><topic>Human behavior</topic><topic>Humans</topic><topic>Hypothetical particles</topic><topic>Ligands</topic><topic>Lipids</topic><topic>Lipoprotein A</topic><topic>Lipoproteins</topic><topic>Lipoproteins, HDL</topic><topic>Lipoproteins, LDL</topic><topic>Low density lipoprotein</topic><topic>Low density lipoprotein receptors</topic><topic>Low density lipoproteins</topic><topic>Medical research</topic><topic>Membrane lipids</topic><topic>Monoclonal antibodies</topic><topic>Oxidation</topic><topic>Phospholipids</topic><topic>Plasma</topic><topic>Proteins</topic><topic>Review</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Itabe, Hiroyuki</creatorcontrib><creatorcontrib>Obama, Takashi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Itabe, Hiroyuki</au><au>Obama, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2023-03-17</date><risdate>2023</risdate><volume>24</volume><issue>6</issue><spage>5747</spage><pages>5747-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>A high concentration of low-density lipoproteins (LDLs) in circulation has been well-known as a major risk factor for cardiovascular diseases. The presence of oxidized LDLs (oxLDLs) in atherosclerotic lesions and circulation was demonstrated using anti-oxLDL monoclonal antibodies. The so-called "oxLDL hypothesis", as a mechanism for atherosclerosis development, has been attracting attention for decades. However, the oxLDL has been considered a hypothetical particle since the oxLDL present in vivo has not been fully characterized. Several chemically modified LDLs have been proposed to mimic oxLDLs. Some of the subfractions of LDL, especially Lp(a) and electronegative LDL, have been characterized as oxLDL candidates as oxidized phospholipids that stimulate vascular cells. Oxidized high-density lipoprotein (oxHDL) and oxLDL were discovered immunologically in vivo. Recently, an oxLDL-oxHDL complex was found in human plasma, suggesting the involvement of HDLs in the oxidative modification of lipoproteins in vivo. In this review, we summarize our understanding of oxidized lipoproteins and propose a novel standpoint to understand the oxidized lipoproteins present in vivo.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>36982815</pmid><doi>10.3390/ijms24065747</doi><orcidid>https://orcid.org/0000-0002-8044-9494</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2023-03, Vol.24 (6), p.5747
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10053446
source Publicly Available Content Database; PubMed Central
subjects Arteriosclerosis
Atherosclerosis
Atherosclerosis - etiology
Blood lipids
Blood plasma
Cardiovascular diseases
Cardiovascular Diseases - complications
Cholesterol
Development and progression
Electronegativity
Enzymes
High density lipoprotein
Human acts
Human behavior
Humans
Hypothetical particles
Ligands
Lipids
Lipoprotein A
Lipoproteins
Lipoproteins, HDL
Lipoproteins, LDL
Low density lipoprotein
Low density lipoprotein receptors
Low density lipoproteins
Medical research
Membrane lipids
Monoclonal antibodies
Oxidation
Phospholipids
Plasma
Proteins
Review
Risk Factors
title The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T23%3A54%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Oxidized%20Lipoproteins%20In%20Vivo:%20Its%20Diversity%20and%20Behavior%20in%20the%20Human%20Circulation&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Itabe,%20Hiroyuki&rft.date=2023-03-17&rft.volume=24&rft.issue=6&rft.spage=5747&rft.pages=5747-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms24065747&rft_dat=%3Cgale_pubme%3EA751926824%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c546t-434ab210582af0f7743e35b686b47b7909710d21347448aa2c29e326abc072e23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2791656819&rft_id=info:pmid/36982815&rft_galeid=A751926824&rfr_iscdi=true